This will be a star stock. I will vary from high to low until the FDA timeline is announced. The price movement until the FDA announcement is irrelevant and is determined by cash needs of existing investors.
Once the. Company advises the FDA timeline we will be on a pathway to a $1-2b valuation which is $10+ a share.
There is little risk to get my forecast - all we need to see is for time to pass.
I have a lot of confidence in management. They have done everything right and next step is to get FDA approval and then to sign a few licence agreements starting with USA.
DYOR but the equation is pretty clear.
Can’t wait to see so many happy shareholders.
be patient and let the traders and early shareholders sell out. If you chose to accumulate during this period lucky you.
Enjjoy the ride.
LTP Price at posting:
69.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)